Reduced neutralizing antibody potency of <scp>COVID</scp> ‐19 convalescent vaccinated plasma against <scp>SARS‐CoV</scp> ‐2 Omicron variant-Reference-Cited by-同舟云学术

Reduced neutralizing antibody potency of COVID ‐19 convalescent vaccinated plasma against SARS‐CoV ‐2 Omicron variant

Published:2022-05-16 Issue:7 Volume:117 Page:971-975
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sanguinis

Author:

Gallian Pierre¹²^ORCID,Amroun Abdennour²,Laperche Syria¹²,Le Cam Sophie¹^ORCID,Brisbarre Nadège²³,Malard Lucile¹,Nurtop Elif²,Isnard Christine²³,Richard Pascale¹,Morel Pascal¹⁴,Tiberghien Pierre¹⁴^ORCID,de Lamballerie Xavier²

Affiliation:

1. Etablissement Français du Sang La Plaine Saint Denis France

2. Unité des Virus Emergents (UVE: Aix‐Marseille Univ, IRD 190, Inserm 1207) Marseille France

3. Etablissement français du Sang Provence Alpes Côte d'Azur et Corse Marseille France

4. UMR RIGHT 1098, Inserm, Etablissement Français du Sang University of Franche‐Comté Besançon France

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.13279

Reference22 articles.

1. Heavily mutated Omicron variant puts scientists on alert

2. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

3. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance

4. COVID‐19 Point épidémiologique 27 janvier2022. N°100. Santé Publique France. Available from:https://www.santepubliquefrance.fr/maladies‐et‐traumatismes/maladies‐et‐infections‐respiratoires/infection‐a‐coronavirus/documents/bulletin‐national/covid‐19‐point‐epidemiologique‐du‐27‐janvier‐2022

5. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covid-19 : encore une place pour le plasma de convalescent ? Focus sur les patients immunodéprimés;La Revue de Médecine Interne;2023-09

2. High‐titer post‐vaccine COVID‐19 convalescent plasma for immunocompromised patients during the first omicron surge;Transplant Infectious Disease;2023-03-16

3. Low neutralization capacity against SARS‐CoV‐2 Omicron BQ.1.1 of convalescent plasma collected during circulation of Omicron BA.1;Vox Sanguinis;2023-03-10